https://www.selleckchem.com/pr....oducts/blebbistatin.
11 vs 21.42days; mean difference, 0.71; 95% CI, 0.50-1.0, nosocomial infection rates (4.13 vs 5.84/1000 hospital days; mean ratio, 0.67; 95% CI, 0.47-0.96), antibiotic exposure (38.63 vs 57.32/100 hospital days; mean ratio, 0.67; 95% CI, 0.47-0.96), breastfeeding rates (87.25% vs 55.78%; OR, 5.42; 95% CI, 3.25-9.05), and rehospitalization rates (3.65% vs 7.48%; OR, 0.47; 95% CI, 0.28-0.77). At follow-up to 18months, breastfeeding rates and weight were significantly (P.05) higher over time in the FICare group. FICare was feasi
Like
Comment
Share
